NEW MJ NEWS

Trulieve Announces January 2022 Investor Conference Participation

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced upcoming participation in various investor conferences in January.

Trulieve logo
Trulieve logo
ICR Conference, January 10, 2022: Founder and CEO Kim Rivers will participate in a fireside chat and investor meetings.

ATB Capital Markets 10th Annual Institutional Investor Conference, January 13, 2022: President Steve White will participate in a panel discussion and investor meetings.

Needham 24th Annual Growth Conference, January 14, 2022: Founder and CEO Kim Rivers will participate in a panel discussion and investor meetings.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve
Twitter: @Trulieve

Investor Contact
Christine Hersey, Director of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Rob Kremer, Executive Director of Corporate Communications
+1 (404) 218-3077
Robert.Kremer@Trulieve.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-january-2022-investor-conference-participation-301454501.html

SOURCE Trulieve Cannabis Corp.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$PMCB Advances Cannabinoid Research With Schedule 1 License

PharmaCyte Biotech Advances Cannabinoid Research With Schedule 1 License PharmaCyte Biotech, Inc.…

$PMCB New Research Shows Melligen Cell Line Can Reverse Diabetes

New Research Shows PharmaCyte Biotech’s Melligen Cell Line Can Reverse Diabetes Diabetes…

 Player’s Network, Inc. (PNTV) Shareholder 2019 Year in Review and 2020 Outlook

Players Network, Inc. Shareholder 2019 Year in Review and 2020 Outlook  …

1933 Industries Inc. (TGIFF) Enters High Value Cannabis Flower Market in Nevada

1933 Industries Enters High Value Cannabis Flower Market in Nevada 1933 Industries…